176 related articles for article (PubMed ID: 7836509)
41. First established pregnancy and birth after induction of ovulation with recombinant human follicle-stimulating hormone in polycystic ovary syndrome.
van Dessel HJ; Donderwinkel PF; Coelingh Bennink HJ; Fauser BC
Hum Reprod; 1994 Jan; 9(1):55-6. PubMed ID: 8195351
[TBL] [Abstract][Full Text] [Related]
42. Measurement of serum levels of exogenously administered FSH and LH during ovulation induction therapy.
Mallya S; Abdulla UA; Davis JC
Gynecol Endocrinol; 1993 Sep; 7(3):167-71. PubMed ID: 8291453
[TBL] [Abstract][Full Text] [Related]
43. Ovarian stimulation in obese and non-obese polycystic ovary syndrome using a low-dose step-up regimen with two different starting doses of recombinant follicle-stimulating hormone.
Yildizhan R; Adali E; Kolusari A; Kurdoglu M; Yildizhan B; Sahin HG; Kamaci M
J Int Med Res; 2008; 36(6):1197-204. PubMed ID: 19094427
[TBL] [Abstract][Full Text] [Related]
44. [Chronic low dose follicle stimulating hormone step-up regimen in the treatment of polycystic ovary syndrome related anovulatory infertility with clomiphene resistance].
Chen W; Zhang Y; Dai Q
Zhonghua Fu Chan Ke Za Zhi; 2000 Oct; 35(10):588-90. PubMed ID: 11372406
[TBL] [Abstract][Full Text] [Related]
45. The impact of a gonadotropin-releasing hormone antagonist on gonadotropin ovulation induction cycles in women with polycystic ovary syndrome: a prospective randomized study.
Stadtmauer LA; Sarhan A; Duran EH; Beydoun H; Bocca S; Pultz B; Oehninger S
Fertil Steril; 2011 Jan; 95(1):216-20. PubMed ID: 20594551
[TBL] [Abstract][Full Text] [Related]
46. Pure FSH for ovulation induction in patients with polycystic ovary syndrome and resistant to clomiphene citrate therapy.
Neyro JL; Barrenetxea G; Montoya F; Rodriguez-Escudero FJ
Hum Reprod; 1991 Feb; 6(2):218-21. PubMed ID: 1905311
[TBL] [Abstract][Full Text] [Related]
47. Validation of a prediction model for the follicle-stimulating hormone response dose in women with polycystic ovary syndrome.
van Wely M; Fauser BC; Laven JS; Eijkemans MJ; van der Veen F
Fertil Steril; 2006 Dec; 86(6):1710-5. PubMed ID: 17022982
[TBL] [Abstract][Full Text] [Related]
48. The prognostic value of basal luteinizing hormone:follicle-stimulating hormone ratio in the treatment of patients with polycystic ovarian syndrome by assisted reproduction techniques.
Tarlatzis BC; Grimbizis G; Pournaropoulos F; Bontis J; Lagos S; Spanos E; Mantalenakis S
Hum Reprod; 1995 Oct; 10(10):2545-9. PubMed ID: 8567767
[TBL] [Abstract][Full Text] [Related]
49. Cohort size rather than follicle-stimulating hormone threshold level determines ovarian sensitivity in polycystic ovary syndrome.
Van Der Meer M; Hompes PG; De Boer JA; Schats R; Schoemaker J
J Clin Endocrinol Metab; 1998 Feb; 83(2):423-6. PubMed ID: 9467551
[TBL] [Abstract][Full Text] [Related]
50. Different follicle stimulating hormone/luteinizing hormone ratios for ovarian stimulation.
Duijkers IJ; Vemer HM; Hollanders JM; Willemsen WN; Bastiaans LA; Hamilton CJ; Thomas CM; Borm GF
Hum Reprod; 1993 Sep; 8(9):1387-91. PubMed ID: 8253923
[TBL] [Abstract][Full Text] [Related]
51. Chronic ultra-low dose follicle-stimulating hormone regimen for patients with polycystic ovary syndrome: one click, one follicle, one pregnancy.
Orvieto R; Homburg R
Fertil Steril; 2009 Apr; 91(4 Suppl):1533-5. PubMed ID: 18990384
[TBL] [Abstract][Full Text] [Related]
52. [Clinical therapeutic effects of acupuncture combined with Chinese herbal medicine on infertility of polycystic ovary syndrome in the patients with ovulation induction with letrozole].
Yin Y; Zhang Y; Zhang H; Jiang D; Guo G
Zhongguo Zhen Jiu; 2018 Jan; 38(1):27-32. PubMed ID: 29354933
[TBL] [Abstract][Full Text] [Related]
53. Recombinant versus highly-purified, urinary follicle-stimulating hormone (r-FSH vs. HP-uFSH) in ovulation induction: a prospective, randomized study with cost-minimization analysis.
Revelli A; Poso F; Gennarelli G; Moffa F; Grassi G; Massobrio M
Reprod Biol Endocrinol; 2006 Jul; 4():38. PubMed ID: 16848893
[TBL] [Abstract][Full Text] [Related]
54. Does metformin affect the ovarian response to gonadotropins for in vitro fertilization treatment in patients with polycystic ovary syndrome and reduced ovarian reserve? A randomized controlled trial.
Palomba S; Falbo A; Di Cello A; Cappiello F; Tolino A; Zullo F
Fertil Steril; 2011 Nov; 96(5):1128-33. PubMed ID: 21917254
[TBL] [Abstract][Full Text] [Related]
55. Letrozole induction of ovulation in women with clomiphene citrate-resistant polycystic ovary syndrome may not depend on the period of infertility, the body mass index, or the luteinizing hormone/follicle-stimulating hormone ratio.
Elnashar A; Fouad H; Eldosoky M; Saeid N
Fertil Steril; 2006 Feb; 85(2):511-3. PubMed ID: 16595244
[TBL] [Abstract][Full Text] [Related]
56. Porcine follicle-stimulating hormone treatment of gilts during an altrenogest-synchronized follicular phase: effects on follicle growth, hormone secretion, ovulation, and fertilization.
Guthrie HD; Pursel VG; Wall RJ
J Anim Sci; 1997 Dec; 75(12):3246-54. PubMed ID: 9419999
[TBL] [Abstract][Full Text] [Related]
57. Endocrine and follicle characteristics of cycles with and without endogenous luteinizing hormone surges during superovulation induction with pulsatile follicle-stimulating hormone.
Messinis IE; Templeton AA
Hum Reprod; 1987 Jan; 2(1):11-6. PubMed ID: 3106404
[TBL] [Abstract][Full Text] [Related]
58. [Contribution of pure FSH in ovulation induction excluding fertilization in vitro].
Buvat J; Buvat-Herbaut M; Marcolin G; Verbecq P
Rev Fr Gynecol Obstet; 1991 Feb; 86(2):91-6. PubMed ID: 1905833
[TBL] [Abstract][Full Text] [Related]
59. Ovarian luteinizing hormone priming preceding follicle-stimulating hormone stimulation: clinical and endocrine effects in women with long-term hypogonadotropic hypogonadism.
Balasch J; Fábregues F; Carmona F; Casamitjana R; Tena-Sempere M
J Clin Endocrinol Metab; 2009 Jul; 94(7):2367-73. PubMed ID: 19366842
[TBL] [Abstract][Full Text] [Related]
60. Endocrine response determines the clinical outcome of pulsatile gonadotropin-releasing hormone ovulation induction in different ovulatory disorders.
Filicori M; Flamigni C; Meriggiola MC; Ferrari P; Michelacci L; Campaniello E; Valdiserri A; Cognigni G
J Clin Endocrinol Metab; 1991 May; 72(5):965-72. PubMed ID: 1902487
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
